Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027161 Human cDNAs and proteins and uses thereof
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins
02/06/2003US20030027151 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders
02/06/2003US20030027146 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027145 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders
02/06/2003US20030027144 Nucleotide sequences coding protein for use in the treatment cancer
02/06/2003US20030027143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/06/2003US20030027139 Polynucleotides encoding novel secreted proteins
02/06/2003US20030027137 Novel nuclear receptor corepressor molecules and uses therefor
02/06/2003US20030027132 Secreted Protein HODAZ50
02/06/2003US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases
02/06/2003US20030027124 Genetically engineering cell structure; obtain cells, amplify intracellular concentration of preferential enzymatic polypeptide, monitor structure of cell
02/06/2003US20030026861 Anticancer agents; from soybeans
02/06/2003US20030026855 Concentrates containing fluorocarbon; oxygenation
02/06/2003US20030026842 Production of hard, dense particles
02/06/2003US20030026820 Use of a compositon containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin
02/06/2003US20030026812 Administering amylin, or peptide antagonist thereof
02/06/2003US20030026804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
02/06/2003US20030026802 Interference with binding chemokines
02/06/2003US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
02/06/2003US20030026799 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030026798 In situ dissolving of deposits
02/06/2003US20030026797 Antifungal compositions
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026794 Topical applying proteolytic enzyme; removal of skin layers
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
02/06/2003US20030026792 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
02/06/2003US20030026789 Anticancer agents
02/06/2003US20030026784 Cardiovascular disorders; genetic engineered mouse
02/06/2003US20030026783 Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal transgenesis and in functional inactivation of an endogenous proteins
02/06/2003US20030026781 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
02/06/2003US20030026779 Complex; genetic engineering
02/06/2003US20030026778 Chimeric cytokines and uses thereof
02/06/2003US20030026777 Detection and treatment of breast disease
02/06/2003US20030026767 Method to aerosolize Interferon-Gamma for lung delivery for local and systemic treatments
02/06/2003US20030024482 Programmable electronic maze for use in the assessment of animal behavior
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2493596A1 Novel targeted delivery system for bioactive agents
02/06/2003CA2455681A1 An inducer of apoptosis
02/06/2003CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
02/06/2003CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor
02/06/2003CA2454824A1 Treatment of immune disorders and b cell disorders
02/06/2003CA2454791A1 Antisense modulation of c-reactive protein expression
02/06/2003CA2454734A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
02/06/2003CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003CA2454342A1 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003CA2453894A1 Antisense modulation of hormone-sensitive lipase expression
02/06/2003CA2453653A1 Gmg-2 polynucleotides and polypeptides and uses thereof
02/06/2003CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor
02/05/2003EP1281775A2 Identification and use of molecules implicated in pain
02/05/2003EP1281763A2 Early growth response-1 (EGR-1) transcription factor
02/05/2003EP1281761A1 Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof.
02/05/2003EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents
02/05/2003EP1281758A2 Four human zinc-finger-containing proteins : MDZ3, MDZ4, MDZ7 and MDZ12
02/05/2003EP1281756A1 Regulator of calcineurin
02/05/2003EP1281719A1 A human cyclic nucleotide gated channel family member, referred as "9721", and uses thereof
02/05/2003EP1281702A2 Calcium receptor active molecules
02/05/2003EP1281404A2 Use of antibodies against the urokinase receptor
02/05/2003EP1281396A2 Skin vitalizing composition for external use anti-aging preparation
02/05/2003EP1281351A2 Diabetes management system
02/05/2003EP1281325A1 Nutritional composition preventing bacterial overgrowth
02/05/2003EP1281323A1 Compositions containing peptide and electrolyte excretion promoter and foods containing the same
02/05/2003EP1281083A1 Methods for detecting inflammation and inflammatory conditions
02/05/2003EP1280924A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
02/05/2003EP1280923A2 14094, a human trypsin family member and uses thereof
02/05/2003EP1280922A2 21953, a human prolyl oligopeptidase family member and uses thereof
02/05/2003EP1280918A2 Lipid metabolism enzymes
02/05/2003EP1280914A1 Tt virus polypeptide, nucleic acid coding for said polypeptide and uses
02/05/2003EP1280911A2 Regulatory nucleic acid sequences of the ABC1 gene
02/05/2003EP1280909A2 Human lipocalin homologs and polynucleotides encoding the same
02/05/2003EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
02/05/2003EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
02/05/2003EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
02/05/2003EP1280905A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene carboxy terminal peptides
02/05/2003EP1280904A2 Pain signaling molecules
02/05/2003EP1280903A2 Ph domain-interacting protein
02/05/2003EP1280901A1 3d structure of polypeptides containing a tpr-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said peptides
02/05/2003EP1280900A2 Dendritic cell co-stimulatory molecules
02/05/2003EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
02/05/2003EP1280898A1 Modified es cells and es cell-specific gene
02/05/2003EP1280895A2 Polypeptide inhibiting a proton-gated na?+ channel
02/05/2003EP1280890A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
02/05/2003EP1280889A2 Compositions and methods for producing antigen-presenting cells
02/05/2003EP1280826A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
02/05/2003EP1280825A2 Regulation of human g protein-coupled receptor
02/05/2003EP1280824A2 Human ion channels
02/05/2003EP1280820A2 Anti-inflammatory compounds and uses thereof
02/05/2003EP1280815A1 29 human secreted proteins
02/05/2003EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
02/05/2003EP1280576A2 Dispensing devices and liquid formulations
02/05/2003EP1280572A1 Delivery devices for treatment of vascular disease
02/05/2003EP1280570A2 Delivery devices for treatment of vascular disease
02/05/2003EP1280569A1 Delivery systems for treatment of vascular disease
02/05/2003EP1280568A1 Delivery devices for treatment of vascular disease
1 ... 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 ... 3163